
News from Eyewire+
Top Eyewire+ News

Paris, France · ParisMILAN, Sept. 05, 2025 (GLOBE NEWSWIRE) -- AAVantgarde Bio (AAVantgarde), a clinical-stage biotechnology company developing next-generation gene therapies for inherited retinal diseases, today announced the presentation of updated clinical data from the LUCE-1 study at the 25th European Society of Retina Specialists (EURETINA) Annual Congress (EURetina 2025), taking place in Paris 4-7 September 2025. Data presented by Prof. Simonelli included saf…See the Story
AAVantgarde presents updated positive clinical data from its AAVB-081 program for Usher 1B at EURetina 2025
57% Left coverage: 7 sources

Oculis and EURETINA Announce the Winner of the Ramin Tadayoni Award 2025
100% Right coverage: 1 sources